Delivery Order SPE2DB22D2211-SPE2DB25FRGXT

Award Date 10/15/24
Potential Completion Date 10/16/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRGXT
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a delivery order contract worth $1,094.44 for the supply of 4566110547 - Pimecrolimus 1% Cream 100 gm. The contract, which has a completion date of October 16, 2024, is a firm fixed-price award with no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of essential medical products, including specialty medications, drugs, and medical supplies, to support military treatment facilities, veterans' hospitals, and other government healthcare programs. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for the company to deliver pharmaceutical and medical commodities to various federal agencies.

Generated 1/14/25, 9:20 AM